The Many Faces of Glioblastoma-Associated Macrophages and Their Gene Signatures

Mikael S Lindström1

  • 1Science for Life Laboratory, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-171 77 Stockholm, Sweden.

Cancers
|February 27, 2026
PubMed

Insights

High-grade gliomas, including glioblastoma (GBM), have a poor prognosis. This study explores novel therapeutic strategies to improve outcomes for patients with these aggressive brain tumors.

Area of Science:

  • Neuro-oncology
  • Cancer biology

Background:

  • High-grade gliomas, especially glioblastoma (GBM), present a significant clinical challenge.
  • Current treatment options offer limited efficacy, leading to poor patient prognoses.